Skip to main content

Table 1 Characteristics of participants with spinal cord injury

From: Retraining walking over ground in a powered exoskeleton after spinal cord injury: a prospective cohort study to examine functional gains and neuroplasticity

Participant code-gender Age range Neurological level of injury AIS Cause of injury Time since injury (yr) Anti-spastic medication
P1 2 T3 B MVA 4.2 Baclofen
P2 1 C7 C MVA 5.7 Baclofen, Tizanidine, Oxybutynin
P3 1 C6 C MVA 2.5 Baclofen, Oxybutynin
P4 3 T6 A! Crush injury 24.2 Baclofen, Diazepam, Oxybutynin
P5 2 T4 A! Sports 16.2 Oxybutynin
P6 2 T3 A MVA 4.3 Oxybutynin
P7 1 T7 A MVA 2.4 Baclofen, Oxybutinin
P8 2 T9 A Fall 1.3 Oxybutynin
P9 1 T10 B! MVA 2.0 Baclofen
P10 2 T4 C MVA 4.4 Baclofen, Oxybutinin
P11 3 C6 D! MVA 18.7 Baclofen
P12 1 T7 A! MVA 1.6 Baclofen
  1. Age ranges are used rather than exact numbers to avoid potential identification of individuals. Age range: 1 = 18–30 yr., 2 = 31–50 yr., 3 = 50–65 yr. The mean and SD for age were calculated from the actual age of each participant. AIS was that obtained in discharge summaries from rehabilitation centers unless otherwise indicated. AIS - ASIA Impairment Scale, T – thoracic, C – cervical, MVA - motor vehicle accident, SD - standard deviation. Symbols: aMean and SD do not include P6 who dropped out after 2 sessions of training. !AIS results not available from records or never performed, so AIS was estimated based on muscle strength scores and sensory perception. Evaluation occurred prior to occurrence of syrinx. Syrinx was operated on and resolved before participation in this study